The stock, with a market capitalisation of more than Rs 25,000 crore, hit a 52-week high of Rs 2,261 on 16 November 2021 and since then the stock went sideways. It hit a low of Rs 1,655 in March 2022, and Rs 1,608 in June 2022.
Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?
Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defence, Capital Markets, and Metals—are showing remarkable strength.